Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that certain RNA circles in the brain are linked to disease risk, but their exact role in disease is still unknown.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

CXCL7 is essential for muscle repair by aiding early neutrophil infiltration.

Increased energy use in Pik3r1-related insulin resistance isn't due to Ucp1 thermogenesis.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

rPanglaoDB helps study rare cell types by merging RNA data, showing fibrocytes aid in healing.

Hypospadiac rats showed abnormal genital development, useful for studying human hypospadias.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

A new method was developed to accurately detect and measure 47 different drug ingredients in various products.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Leporacarus gibbus mite was found in a domestic rabbit in Espírito Santo, Brazil, for the first time.

MicroRNA-302 helps improve the conversion of body cells into stem cells by blocking NR2F2.

Non-itchy rashes can indicate serious diseases like lupus.

17β-estradiol can reduce inflammation in the skin.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

TRPV4 channel affects skin health and could be a target for treating skin disorders.

Specialized ribosomes affect aging in human skin cells.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

The new compound may be a safer alternative to finasteride for prostate protection.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Foals with Rhodococcus equi infection often have other health problems that lower their chances of survival.

Narrowband-UVB phototherapy successfully treated a rare case of Graham Little-Piccardi-Lassueur syndrome.

GRF is not safe for tubal occlusion.

Virus infection risk is linked to heat tolerance and size, but decreases with high humidity and mutation rates.